Hageman factor and its binding sites are present in senile plaques of Alzheimer's disease

[1]  P. Mcgeer,et al.  Thrombin accumulation in brains of patients with Alzheimer's disease , 1992, Neuroscience Letters.

[2]  D. Walker,et al.  Complement gene expression in human brain: comparison between normal and Alzheimer disease cases. , 1992, Brain research. Molecular brain research.

[3]  P. Mcgeer,et al.  Immune System Response in Alzheimer's Disease , 1989, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[4]  F. Kametani,et al.  THE IMMUNOHISTOCHEMICAL DEMONSTRATION OF SUBSEQUENCES OF THE PRECURSOR OF THE AMYLOID A4 PROTEIN IN SENILE PLAQUES IN ALZHEIMER'S DISEASE , 1989, Neuropathology and applied neurobiology.

[5]  P. Eikelenboom,et al.  Complement activation in amyloid plaques in Alzheimer’s dementia , 1988, Virchows Archiv. B, Cell pathology including molecular pathology.

[6]  D. Nochlin,et al.  The presence of heparan sulfate proteoglycans in the neuritic plaques and congophilic angiopathy in Alzheimer's disease. , 1988, The American journal of pathology.

[7]  R. MacGillivray,et al.  Characterization of the human blood coagulation factor XII gene. Intron/exon gene organization and analysis of the 5'-flanking region. , 1987, The Journal of biological chemistry.

[8]  R. Colman,et al.  A monoclonal antibody recognizing an icosapeptide sequence in the heavy chain of human factor XII inhibits surface-catalyzed activation. , 1987, The Journal of biological chemistry.

[9]  J. Dunn,et al.  Mechanisms of activation of the classical pathway of complement by Hageman factor fragment. , 1983, The Journal of clinical investigation.

[10]  O. Ratnoff,et al.  Radioimmunoassay of human Hageman factor (factor XII). , 1976, The Journal of laboratory and clinical medicine.

[11]  O. Ratnoff,et al.  A familial hemorrhagic trait associated with a deficiency of a clot-promoting fraction of plasma. , 1955, The Journal of clinical investigation.